브린졸라미드

동물 종별 용량

용량은 면허 수의 전문가를 위한 임상 참고 자료입니다. 항상 최신 라벨과 개별 환자에 대해 확인하십시오.

투여 경로

금기

• Severe hepatic impairment
• Severe renal impairment
• Uveitis (specifically for the timolol combination, as timolol causes miosis)
• Anterior lens luxation (timolol combination)
• Pupil block (timolol combination)

이상반응

• Local ocular irritation
• Keratitis
• Blepharitis
• Hypokalaemia (cats, rare systemic effect)
• Metabolic acidosis (dogs, rare systemic effect)
• Bradycardia and hypotension (if using the timolol combination product)

모니터링

• Intraocular pressure (IOP)
• Signs of local ocular irritation (keratitis, blepharitis)
• Serum potassium and acid-base status (if prolonged use or systemic signs occur)
• Heart rate and blood pressure (if using timolol combination)

과용량

Excessive topical application may increase the risk of systemic absorption, potentially leading to **metabolic acidosis** or **hypokalaemia** (especially in cats). If the timolol combination is used, overdose may lead to significant **bradycardia** and **hypotension**. Treatment is supportive and symptomatic.